Skip to main content

Friedman Paul A's Form 4 filing

Madrigal Pharmaceuticals, Inc. (MDGL) · filed Apr 5, 2024

Accession no.
0000899243-24-000265
Filed
Apr 5, 2024
Trade date
Apr 3-5, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 23 non-derivative transactions and 3 derivative transactions. Open-market sales total $18.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Friedman Paul ACIK 0001236927Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 3, 2024Common StockMOption exerciseAcquired+27,407$9.45+$258,996.15213,142Direct
Apr 3, 2024Common StockSSaleDisposed−185$242.00−$44,770212,957Direct
Apr 3, 2024Common StockSSaleDisposed−2,294$243.64F2−$558,910.16210,663Direct
Apr 3, 2024Common StockSSaleDisposed−4,301$244.58F3−$1,051,938.58206,362Direct
Apr 3, 2024Common StockSSaleDisposed−18,806$245.34F4−$4,613,864.04187,556Direct
Apr 3, 2024Common StockSSaleDisposed−1,821$246.31F5−$448,530.51185,735Direct
Apr 4, 2024Common StockMOption exerciseAcquired+18,710$9.45+$176,809.5204,445Direct
Apr 4, 2024Common StockSSaleDisposed−6,273$241.07F6−$1,512,232.11198,172Direct
Apr 4, 2024Common StockSSaleDisposed−5,299$242.25F7−$1,283,682.75192,873Direct
Apr 4, 2024Common StockSSaleDisposed−1,467$243.00F8−$356,481191,406Direct
Apr 4, 2024Common StockSSaleDisposed−627$244.31F9−$153,182.37190,779Direct
Apr 4, 2024Common StockSSaleDisposed−2,549$245.14F10−$624,861.86188,230Direct
Apr 4, 2024Common StockSSaleDisposed−1,558$246.13F11−$383,470.54186,672Direct
Apr 4, 2024Common StockSSaleDisposed−737$247.14F12−$182,142.18185,935Direct
Apr 4, 2024Common StockSSaleDisposed−200$248.43F13−$49,686185,735Direct
Apr 5, 2024Common StockMOption exerciseAcquired+27,613$9.45+$260,942.85213,348Direct
Apr 5, 2024Common StockSSaleDisposed−1,420$240.10F14−$340,942211,928Direct
Apr 5, 2024Common StockSSaleDisposed−612$241.15F15−$147,583.8211,316Direct
Apr 5, 2024Common StockSSaleDisposed−6,679$242.42F16−$1,619,123.18204,637Direct
Apr 5, 2024Common StockSSaleDisposed−9,264$243.20F17−$2,253,004.8195,373Direct
Apr 5, 2024Common StockSSaleDisposed−3,966$244.22F18−$968,576.52191,407Direct
Apr 5, 2024Common StockSSaleDisposed−5,228$245.35F19−$1,282,689.8186,179Direct
Apr 5, 2024Common StockSSaleDisposed−444$245.92F20−$109,188.48185,735Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 3, 2024Common StockMOption exerciseDisposed−27,407$0.00$0278,849Direct
Apr 4, 2024Common StockMOption exerciseDisposed−18,710$0.00$0260,139Direct
Apr 5, 2024Common StockMOption exerciseDisposed−27,613$0.00$0232,526Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.00 to $243.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.04 to $245.03, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.04 to $246.01, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.09 to $246.57, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.52 to $241.46, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.59 to $242.57, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.60 to $243.55, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.65 to $244.63, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.65 to $245.61, inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.65, inclusive.

Referenced by the price of 1 transaction in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.80 to $247.54, inclusive.

Referenced by the price of 1 transaction in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.41 to $248.44, inclusive.

Referenced by the price of 1 transaction in Table I.

F14

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.67 to $240.64, inclusive.

Referenced by the price of 1 transaction in Table I.

F15

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.67 to $241.64, inclusive.

Referenced by the price of 1 transaction in Table I.

F16

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.795 to $242.78, inclusive.

Referenced by the price of 1 transaction in Table I.

F17

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.80 to $243.79, inclusive.

Referenced by the price of 1 transaction in Table I.

F18

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.80 to $244.79, inclusive.

Referenced by the price of 1 transaction in Table I.

F19

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.83 to $245.81, inclusive.

Referenced by the price of 1 transaction in Table I.

F20

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.86 to $246.02, inclusive.

Referenced by the price of 1 transaction in Table I.

Remarks

Exhibit 24 - Power of Attorney

Read the full filing on SEC EDGAR (opens in a new tab)